Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Infiltration for Post-Cesarean Pain
NCT04728308Phase 1Unknown
- Sponsor
- Combined Military Hospital
- Start
- Jan 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing Bupivacaine Infiltration with Placebo Infiltration (2 arms). Primary endpoints: Visual Analogue Scale at 12 hours and Total opioid consumption at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04728308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728308.